Passos Livia S A, Nunes Maria Carmo P, Aikawa Elena
The Center for Excellence in Vascular Biology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States.
Hospital das Clínicas e Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Front Cardiovasc Med. 2021 Jan 18;7:612716. doi: 10.3389/fcvm.2020.612716. eCollection 2020.
Rheumatic heart valve disease (RHVD) is a post-infectious sequel of acute rheumatic fever resulting from an abnormal immune response to a streptococcal pharyngitis that triggers valvular damage. RHVD is the leading cause of cardiovascular death in children and young adults, mainly in women from low and middle-income countries. It is known that long-term inflammation and high degree of fibrosis leads to valve dysfunction due to anatomic disruption of the valve apparatus. However, since public and private investments in RHVD studies are practically inexistent the number of publications is scarce. This disease shows different natural history and clinical presentations as compared to other degenerative heart valve diseases. Although more than five decades passed after the pioneering studies on the pathogenesis of RHVD, it is still unclear how self-tolerance mechanisms fail in this disease, and how humoral and cellular inflammatory responses are interconnected. Despite that pathological mechanisms have been already proposed for RHVD, none of them are able to explain the preferential involvement of the mitral valve. This review focuses on pathophysiology and underlying mechanisms of RHVD.
风湿性心脏瓣膜病(RHVD)是急性风湿热的感染后后遗症,由对链球菌性咽炎的异常免疫反应引发,进而导致瓣膜损害。RHVD是儿童和年轻成年人心血管死亡的主要原因,主要发生在低收入和中等收入国家的女性中。已知长期炎症和高度纤维化会因瓣膜装置的解剖结构破坏而导致瓣膜功能障碍。然而,由于对RHVD研究的公共和私人投资几乎不存在,相关出版物数量稀少。与其他退行性心脏瓣膜病相比,这种疾病表现出不同的自然史和临床表现。尽管关于RHVD发病机制的开创性研究已过去五十多年,但仍不清楚这种疾病中自身耐受机制是如何失效的,以及体液和细胞炎症反应是如何相互关联的。尽管已经提出了RHVD的病理机制,但没有一种能够解释二尖瓣为何会优先受累。本综述聚焦于RHVD的病理生理学及潜在机制。